DocMorris (Switzerland) Price Patterns
| DOCM Stock | 4.02 -0.07 -1.71% |
Momentum
Sell Stretched
Oversold | Overbought |
EPS Estimate Current Year -1.36 | EPS Estimate Next Year -0.92 | Wall Street Target Price 8.3667 | Quarterly Revenue Growth 0.042 |
The hype mapping for DocMorris AG connects headline volume with price response patterns. The peer view highlights how DocMorris' attention patterns differ from comparable assets.
This module tracks attention around DocMorris and presents the data alongside performance cues. The data reflects current sentiment observations.
DocMorris after-hype prediction price | ₣ 3.4 |
Hype signals are presented as complementary context to forecasting, technicals, and analyst estimates. Earnings expectations and momentum indicators provide additional analytical dimensions.
DocMorris |
Mean reversion in DocMorris' price occurs when temporary dislocations correct back toward historical fair value. This tendency of DocMorris' price to converge to an average value over time is called mean reversion. Whether book value, historical earnings multiple, or sector median, the reference point matters for DocMorris' analysis.
After-Hype Price Density Analysis
The after-hype price distribution for DocMorris reflects the range of predicted outcomes based on historical news impact. Wider distributions reflect higher uncertainty, while narrow distributions indicate greater consensus about DocMorris' likely price range. The distribution approach for DocMorris provides an objective framework for evaluating risk and reward tradeoffs.
Next price density |
| Expected price to next headline |
Estimiated After-Hype Price Volatility
The after-hype price boundaries for DocMorris are calculated from DocMorris' historical headline events and subsequent daily moves. DocMorris' after-hype downside and upside margins for the prediction period are 0.17 and 7.56, respectively. These boundaries are derived from DocMorris' past price reactions, not forward-looking forecasts.
Current Value
The next after-hype price estimate for DocMorris AG is modeled on a 3 months horizon and is intended to show how price could normalize after sentiment pressure fades. The practical value is that it frames how far price could retrace or stabilize once the headline cycle loses intensity.
Price Outlook Analysis
Ever seen a Company like DocMorris soar with no clear reason behind the move? Big-money trading in DocMorris can push price moves well past what the core data would suggest. A good rule is that when news hype has no link to earnings, you should watch it more closely.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.48 | 4.13 | 0.18 | 0.05 | 5 Events | 2 Events | In 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
4.02 | 3.40 | 16.87 |
|
Hype Timeline
DocMorris AG is currently traded for 4.02on SIX Swiss Exchange of Switzerland. The company has historical hype elasticity of -0.18, and average elasticity to hype of competition of 0.05. DocMorris is anticipated to decline in value after the next headline, with the price expected to drop to 3.4. The average volatility of media hype impact on the company price is over 100%. The price decline on the next news is expected to be -16.87%, whereas the daily expected return is currently at -0.48%. The volatility of related hype on DocMorris is about 4324.1%, with the expected price after the next announcement by competition of 4.07. About 19.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.41. Some equities with similar Price to Book (P/B) outperform the market in the long run. DocMorris AG recorded a loss per share of 4.58. The company had its last dividend issued on the 22nd of November 2018. The firm completed a 593:292 stock split on 13th of May 2025. Assuming the 90-day trading horizon the next anticipated press release will be in 5 days. The DocMorris Basic Forecasting Models framework offers a quantitative cross-check for DocMorris' projections.Related Hype Analysis
Peer hype analysis for DocMorris aggregates sentiment and news impact data from DocMorris' competitive set. Peer hype analysis captures the cross-asset sentiment signal that flows between DocMorris and its competitive set. Monitoring peer reactions to macro events provides context for anticipating DocMorris's likely response.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| VBSN | IVF Hartmann Holding | 3.00 | 1 per month | 0.00 | 0.03 | 2.88 | -3.38 | 8.66 | |
| CLTN | Coltene Holding AG | -0.60 | 2 per month | 0.00 | -0.05 | 2.90 | -2.69 | 12.85 | |
| NWRN | Newron Pharmaceuticals SpA | -1.20 | 4 per month | 0.00 | -0.08 | 6.60 | -5.71 | 16.79 | |
| SANN | Santhera Pharmaceuticals Holding | 0.66 | 4 per month | 2.94 | 0.1 | 6.30 | -5.06 | 18.11 | |
| MOLN | Molecular Partners AG | 0.16 | 6 per month | 3.26 | 0.07 | 6.55 | -5.12 | 20.70 | |
| ASCN | Ascom Holding AG | 0.29 | 4 per month | 1.81 | 0.17 | 8.82 | -3.15 | 22.09 | |
| SHLTN | S H L | 0.05 | 4 per month | 0.00 | 0.03 | 4.59 | -5.61 | 19.15 | |
| ADXN | Addex Therapeutics | -0.0004 | 5 per month | 0.00 | -0.12 | 6.00 | -8.09 | 27.15 | |
| EVE | Evolva Holding SA | -1.50 | 5 per month | 4.92 | 0.04 | 8.14 | -10.31 | 25.46 |
DocMorris Additional Predictive Modules
Predictive models for DocMorris combine technical indicators with statistical methods to estimate probable price trajectories. Model confidence should be calibrated against recent prediction accuracy for DocMorris, not just historical fit.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Sentiment Indicators & Methodology
Sentiment analysis for DocMorris evaluates news tone, positioning, and narrative momentum. Market mood provides context for tactical execution conditions. DocMorris has a market cap of 198.87 M, ROE of -27.47%.
This section for DocMorris AG is built from periodic company reporting and market reference feeds, with harmonization applied to align reporting definitions. Values may update on different source schedules.
This content is curated and reviewed by:
Rifka Kats - Member of Macroaxis Editorial BoardAlso Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for DocMorris Stock Analysis
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| FinTech Suite Use AI to screen and filter investment opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |